Stem cell fate in cancer growth, progression and therapy resistance.

Nature Reviews. Cancer
Nikki K LytleTannishtha Reya

Abstract

Although we have come a long way in our understanding of the signals that drive cancer growth, and how these signals can be targeted, effective control of this disease remains a key scientific and medical challenge. The therapy resistance and relapse that are commonly seen are driven in large part by the inherent heterogeneity within cancers that allows drugs to effectively eliminate some, but not all, malignant cells. Here, we focus on the fundamental drivers of this heterogeneity by examining emerging evidence that shows that these traits are often controlled by the disruption of normal cell fate and aberrant adoption of stem cell signals. We discuss how undifferentiated cells are preferentially primed for transformation and often serve as the cell of origin for cancers. We also consider evidence showing that activation of stem cell programmes in cancers can lead to progression, therapy resistance and metastatic growth and that targeting these attributes may enable better control over a difficult disease.

References

Mar 22, 1996·Science·D R LeachJ P Allison
Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Nov 2, 2001·Nature·T ReyaI L Weissman
Aug 22, 2002·Nature Reviews. Cancer·Jean Paul Thiery
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yoshiko IwaiNagahiro Minato
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·C Hirschmann-JaxM K Brenner
Jul 12, 2005·Pediatric Blood & Cancer·Stephen P HungerWilliam L Carroll
Nov 3, 2005·Nature Clinical Practice. Oncology·Giuseppe Giaccone
Jun 3, 2006·Developmental Cell·Sarah K BowmanJuergen A Knoblich
Sep 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Julie B SneddonPatrick O Brown
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marija BalicRichard J Cote
Jan 16, 2007·Cancer Cell·Christopher CalabreseRichard J Gilbertson
Feb 24, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James J VredenburghHenry S Friedman
Mar 14, 2007·Cancer Cell·Michail ShipitsinKornelia Polyak
Apr 11, 2007·The Journal of Experimental Medicine·Yuko TadokoroHiromitsu Nakauchi
Jun 8, 2007·Nature·Lin HeGregory J Hannon
Jun 27, 2007·Seminars in Radiation Oncology·David C HodgsonLouis S Constine
Feb 26, 2008·Cell·Juergen A Knoblich
Mar 18, 2008·Cell Stem Cell·Mingfu WuTannishtha Reya
Dec 19, 2008·Nature·Nick BarkerHans Clevers

❮ Previous
Next ❯

Citations

Nov 13, 2018·Journal of Cellular Physiology·Masoud NajafiKeywan Mortezaee
Apr 27, 2019·International Journal of Molecular Sciences·Xihua YueIntaek Lee
Jun 6, 2019·The New England Journal of Medicine·Michael F Clarke
Dec 25, 2019·The Journal of Cell Biology·Jeevisha BajajTannishtha Reya
Jan 5, 2020·Nature Reviews. Drug Discovery·S DepilL Poirot
Feb 27, 2020·Molecular Cancer·Weicheng LiangQi Zhang
Dec 14, 2019·Scientific Reports·Hamid TeimouriAnatoly B Kolomeisky
May 30, 2019·Journal of Experimental & Clinical Cancer Research : CR·Jing HuBo Han
Jul 8, 2020·Chemical Society Reviews·Jiyou HanJong Seung Kim
May 30, 2020·International Journal of Oncology·Nicole A McgrathChangqing Xie
Jul 21, 2020·Nature Communications·Jamie ZagozewskiTamra E Werbowetski-Ogilvie
Mar 22, 2019·International Journal of Radiation Biology·Claudia PeitzschMichael Baumann
Aug 4, 2020·Molecular Oncology·Chelsea Gerada, Kevin M Ryan
May 22, 2019·Journal of Clinical Medicine·Kelvin K TsaiYuval Shaked
Nov 30, 2019·Stem Cells International·Rayana L Bighetti-TrevisanLuciana O Almeida
Feb 8, 2020·Cells·Francisco Triana-MartínezEduardo Domínguez
Apr 23, 2020·Frontiers in Oncology·Qiao-Ru GuoJian-Ye Zhang
Jul 2, 2020·Nature Reviews. Gastroenterology & Hepatology·Jesus M BanalesGregory J Gores
Jun 7, 2020·Cells·Takahiro DomotoToshinari Minamoto
Aug 4, 2020·World Journal of Stem Cells·Xuan ZhuZhi-Gang Chen
Mar 7, 2020·Signal Transduction and Targeted Therapy·Lu DengPing Wang
Jul 23, 2020·Frontiers in Oncology·Yuehui LiangFang Xiao
Aug 18, 2020·OncoTargets and Therapy·Yucong LiQi Zhou
Mar 9, 2019·Frontiers in Oncology·Vincenzo IngangiMaria Vincenza Carriero
Jun 27, 2019·British Journal of Haematology·Alfonso E Bencomo-AlvarezAnna M Eiring
Jan 30, 2020·Journal of Experimental & Clinical Cancer Research : CR·Siqi WangJiye Zhu
Jan 5, 2020·Nature Communications·Antonio ColapricoElena Papaleo
Aug 16, 2019·Nature Reviews. Cancer·J Wolter Oosterhuis, Leendert H J Looijenga
May 14, 2020·International Journal of Molecular Sciences·Anna PastòAntonio Sica

❮ Previous
Next ❯

Methods Mentioned

BETA
histone acetylation
xenografts
single-cell sequencing
xenograft

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Related Papers

Current Oncology Reports
D A Hazelton, T C Hamilton
[Rinshō ketsueki] The Japanese journal of clinical hematology
H Naora
International Journal of Molecular Sciences
Deborah BongiovanniErich Piovan
© 2022 Meta ULC. All rights reserved